drugset / Trial / NCT06123702

Cannabidiol Effects on Fear Extinction in Social Phobia

NCT06123702

Phase 0 Unknown 20 enrolled Hartford Hospital
RandomizedParallel-groupDouble-blindBasic science

Summary

The investigators will randomly assign participants with social anxiety disorder to receive oral cannabidiol (CBD) or placebo. Participants will undergo a fear conditioning and extinction trial, and the investigators will examine whether CBD increases the degree of fear reduction during extinction.

Timeline

Start
2024-04-30
Primary completion
2024-12-31
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Cannabidiol Other / unclassified 600 mg Oral

Indications